Eddie Gray joined Dynavax Technologies Corporation as Chief Executive Officer and was appointed to the board in May 2013. Most recently, Mr. Gray served as the President of Pharmaceuticals Europe at GlaxoSmithKline plc (GSK) since 2008, and as ...
Dynavax Technologies Corporation (NASDAQ:DVAX) has dropped 0.85% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 2.92% in the last 4 weeks.
Dynavax Technologies Corporation (NASDAQ:DVAX) has lost 5.61% during the past week and dropped 8.87% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 8.39%.
Dynavax Technologies Corporation (NASDAQ:DVAX) has shown a rise of 18.8% or 837,519 shares in the short positions. The bets have increased to 5,291,225 shares on January 30,2015 from 4,453,706 shares on January 15,2015.